Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8808 |
High Similarity |
NPD7819 |
Suspended |
0.8741 |
High Similarity |
NPD2796 |
Approved |
0.8671 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD6232 |
Discontinued |
0.8608 |
High Similarity |
NPD7473 |
Discontinued |
0.8542 |
High Similarity |
NPD1510 |
Phase 2 |
0.8531 |
High Similarity |
NPD1607 |
Approved |
0.8471 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8408 |
Intermediate Similarity |
NPD5494 |
Approved |
0.84 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD2532 |
Approved |
0.84 |
Intermediate Similarity |
NPD2534 |
Approved |
0.84 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8392 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8323 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8301 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8278 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8247 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8243 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8205 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8121 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8092 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8054 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD920 |
Approved |
0.805 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8025 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8025 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7987 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7943 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7937 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7935 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7908 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7895 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7803 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7778 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7748 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7748 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7748 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7748 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7744 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7744 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7724 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7716 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7708 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7665 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7654 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD943 |
Approved |
0.7635 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7593 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7582 |
Intermediate Similarity |
NPD2344 |
Approved |
0.756 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7535 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7533 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.753 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6779 |
Approved |
0.75 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD6777 |
Approved |
0.75 |
Intermediate Similarity |
NPD6782 |
Approved |
0.75 |
Intermediate Similarity |
NPD6780 |
Approved |
0.75 |
Intermediate Similarity |
NPD6778 |
Approved |
0.75 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7486 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD37 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1283 |
Approved |
0.745 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7442 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.74 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7399 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7389 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7377 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7377 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7377 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7377 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7366 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7262 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7253 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD17 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7219 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7143 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7135 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7113 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7104 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7104 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7083 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7059 |
Intermediate Similarity |
NPD411 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7034
|
Intermediate Similarity |
NPD5536 |
Phase 2 |